http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0610263-A2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e00ee5c063e875e4e6143ef4519cba4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f596a2ac135474066ebe348783360980 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate | 2006-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7434534a64f0aff12feeec5f57bee522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddbcebc4d8258d496efbebf117aca92a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01c71a123efb0048becdac0ebe457a94 |
publicationDate | 2010-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-PI0610263-A2 |
titleOfInvention | medicament, especially anticancer, for immunotherapy treatment, in particular autologous |
abstract | The invention relates to a medicament comprising at least one biocompatible solid support, preferably powder, on which at least one active substance, preferably chosen from biological materials and / or biological molecules, is adsorbed or adsorbed. on which it is intended to be adsorbed, preferably without requiring coupling agent. This biocompatible solid support being able to purify the active substance. The invention also relates to a process for preparing a medicament of the type mentioned above, which process essentially comprises contacting at least one biocompatible solid support, preferably in powder form, with at least one active substance, preferably chosen. between biological materials and / or biological molecules, so that the active substance adsorbs reversibly and without denaturation on the support. |
priorityDate | 2005-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 235.